Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)

  Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)

Business Wire

PORT WASHINGTON, N.Y. -- April 4, 2013

Pall Corporation (NYSE:PLL), a global leader in filtration, separation and
purification, today confirmed plans for a state-of–the-art Life Sciences
Centre of Excellence at its new Harbourgate site in Portsmouth in the United
Kingdom (UK). The Centre of Excellence (COE), which will open in mid 2013,
will offer a full suite of capabilities including cell culture, purification,
analytical solutions, protein characterization and microbiological tools. This
latest COE will complement recently announced Life Sciences Centres in the
United States (Westborough, Massachusetts and Menlo Park, California) as well
as investments previously announced in China, Singapore and India.

“The announcement of Pall’s new Portsmouth Centre of Excellence provides
another example of our commitment to meeting the diverse needs of our Life
Sciences customers across the globe,” said Yves Baratelli, president, Pall
Life Sciences. "Portsmouth represents an important Life Sciences hub for Pall.
By upgrading and expanding our capabilities at the site, we are not only
enhancing our ability to service our customers, but also creating a
multi-disciplinary and responsive environment in which Pall scientists and
engineers can thrive and innovate.”

The new Portsmouth COE will include a dedicated 4000 m² scientific area with a
connected walkway to another recently opened facility that houses an
additional 2000 m² for Life Sciences technical support and training, R&D
engineering and product management. Manufacturing and test areas will remain
at the current Walton Road site in Portsmouth.

In addition to customer service support, COE offerings will include the
development, testing and validation of a wide range of products that now form
part of Pall's portfolio. There also will be an extensive range of scale-up
technology on hand for applying industry-leading standards to match demands
for fully representative and rapid drug development.

About Pall Life Sciences

Pall Life Sciences provides cutting-edge products and services to meet the
demanding needs of customers discovering, developing and producing biotech
drugs, vaccines and classic pharmaceuticals. Pall’s membranes and membrane
devices optimize detection and sample preparation in the drug research,
clinical diagnostics, genomics, and proteomics markets. Pall is a leading
provider of separation systems and single-use filtration and purification
technologies to pharmaceutical and biotechnology companies to support faster
development of new drugs and vaccines that are safer and require less energy
and water to produce. Pall technologies are also used in clinical institutions
and the food and beverage industries.

About Pall Corporation

Pall Corporation (NYSE:PLL) is a filtration, separation and purification
leader providing solutions to meet the critical fluid management needs of
customers across the broad spectrum of life sciences and industry. Pall works
with customers to advance health, safety and environmentally responsible
technologies. The company’s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a “top green company”
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit
www.pall.com/green.

Contact:

Doug Novarro
Pall Corporation
Corporate Director Public Relations
doug_novarro@pall.com
516-801-9944
Follow us on Twitter @pallcorporation